We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO International ConventionJune 3-6, 2019
BIO World Congress on Industrial Biotechnology and Ag TechJuly 8-11, 2019
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
February 11 - 12, 2019 | New York, New York
Dr. Colón is CEO of InCarda Therapeutics, a senior advisor (and formerly partner) at New Science Ventures and serves on the board of directors of ProterixBio, Paradigm Diagnostics, PerceptiMed and Cocoon Biotech. She is also a member of the Advisory Board of the Miller Center for Social Entrepreneurship at Santa Clara University. Previously, she was founding President of the Industrial Products Division at Intrexon Corporation and held various leadership roles at Gilead Sciences. Prior to Gilead, she was VP, Corporate Planning at Affymetrix, where she also served as COO for the International Genomics Consortium, a non-profit medical research organization focused on cancer genomics. Earlier in her career she was a consultant with McKinsey and an engineer with Merck & Co. in France and in Rahway, NJ. Dr. Colón received her Ph.D. from the Massachusetts Institute of Technology and a B.S. degree from the University of Pennsylvania, both in chemical engineering.
This speaker's sessions: